Correction to: The Strategic Biomarker Roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update

Boccardi, Marina; Dodich, Alessandra; Albanese, Emiliano; Gayet-Ageron, Angèle; Festari, Cristina; Ashton, Nicholas J.; Bischof, Gérard N.; Chiotis, Konstantinos; Leuzy, Antoine; Wolters, Emma E.; Walter, Martin; Rabinovici, Gil D.; Carrillo, Maria; Drzezga, Alexander; Hansson, Oskar; Nordberg, Agneta; Ossenkoppele, Rik; Villemagne, Victor L.; Winblad, Bengt; Frisoni, Giovanni; Garibotto, Valentina

doi:10.1007/s00259-021-05549-z

Correction to: The Strategic Biomarker Roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update

Correction
Published: 21 September 2021

Volume 48, pages 4525–4531, (2021)
Cite this article

Download PDF

European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Correction to: The Strategic Biomarker Roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update

Download PDF

Marina Boccardi^1,2,
Alessandra Dodich^3,4,
Emiliano Albanese⁵,
Angèle Gayet-Ageron⁶,
Cristina Festari⁷,
Nicholas J. Ashton^8,9,10,11,
Gérard N. Bischof¹²,
Konstantinos Chiotis^13,14,
Antoine Leuzy¹³,
Emma E. Wolters¹⁵,
Martin Walter¹⁶,
Gil D. Rabinovici¹⁷,
Maria Carrillo¹⁸,
Alexander Drzezga^19,20,21,
Oskar Hansson^22,23,
Agneta Nordberg^13,24,
Rik Ossenkoppele^25,26,
Victor L. Villemagne^27,28,
Bengt Winblad^24,29,
Giovanni Frisoni^2,30 &
…
Valentina Garibotto^4,16

1503 Accesses
2 Citations
10 Altmetric
1 Mention
Explore all metrics

The Original Article was published on 10 March 2021

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Correction to: Eur J Nucl Med Mol Imaging

https://doi.org/10.1007/s00259-020-05120-2

The authors regret Table 2 needs to be rearranged so that it will be easier to be understood. The corrected Table appears below.

Table 2 Phases for the formal validation of diagnostic biomarkers according to the Strategic Biomarker Roadmap (SBR) for: case finding in oncology (3), diagnosis of Alzheimer’s disease in patients with MCI (2017 adaptation from oncology (1,2)) and the 2020 update of the 2017. AD: Alzheimer’s disease. MCI: mild cognitive impairment. PA: Primary Aim. SA: Secondary Aim

Full size table

Author information

Authors and Affiliations

German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany
Marina Boccardi
LANVIE, Laboratory of Neuroimaging of Aging, University of Geneva, Geneva, Switzerland
Marina Boccardi & Giovanni Frisoni
Center for Neurocognitive Rehabilitation (CeRiN), CIMeC, University of Trento, Trento, Italy
Alessandra Dodich
NIMTlab, Neuroimaging and Innovative Molecular Tracers Laboratory, University of Geneva, Geneva, Switzerland
Alessandra Dodich & Valentina Garibotto
USI, Università della Svizzera Italiana, Lugano, Switzerland
Emiliano Albanese
Clinical Epidemiology Department, University of Geneva, Geneva, Switzerland
Angèle Gayet-Ageron
LANE, Laboratory of Alzheimer’s Neuroimaging and Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
Cristina Festari
Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden
Nicholas J. Ashton
Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
Nicholas J. Ashton
NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation, London, United Kingdom
Nicholas J. Ashton
Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, United Kingdom
Nicholas J. Ashton
Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany
Gérard N. Bischof
Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
Konstantinos Chiotis, Antoine Leuzy & Agneta Nordberg
Theme Neurology, Karolinska University Hospital, Stockholm, Sweden
Konstantinos Chiotis
Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
Emma E. Wolters
Nuclear Medicine and Molecular Division, Geneva Medical Hospital, Geneva, Switzerland
Martin Walter & Valentina Garibotto
Departments of Neurology, Radiology & Biomedical Imaging, University of California, San Francisco, USA
Gil D. Rabinovici
Alzheimer’s Association, Chicago, IL, USA
Maria Carrillo
University of Cologne, Faculty of Medicine, Cologne, Germany
Alexander Drzezga
German Center for Neurodegenerative Diseases (DZNE), Bonn/Cologne, Germany
Alexander Drzezga
Institute of Neuroscience and Medicine (INM-2), Molecular Organization of the Brain, Research Center Jülich, Jülich, Germany
Alexander Drzezga
Clinical Memory Rresearch Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden
Oskar Hansson
Memory Clinic, Skåne University Hospital, Malmö, Sweden
Oskar Hansson
Karolinska University Hospital, Theme Aging, Geriatric Clinic, Huddinge, Sweden
Agneta Nordberg & Bengt Winblad
Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
Rik Ossenkoppele
Department of Clinical Memory Research, Lund University, Lund, Sweden
Rik Ossenkoppele
Department of Molecular Imaging & Therapy, Austin Health, Melbourne, VIC, Australia
Victor L. Villemagne
Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VIC, Australia
Victor L. Villemagne
Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Stockholm, Sweden
Bengt Winblad
Memory Clinic, University Hospital, Geneva, Switzerland
Giovanni Frisoni

Authors

Marina Boccardi
View author publications
You can also search for this author in PubMed Google Scholar
Alessandra Dodich
View author publications
You can also search for this author in PubMed Google Scholar
Emiliano Albanese
View author publications
You can also search for this author in PubMed Google Scholar
Angèle Gayet-Ageron
View author publications
You can also search for this author in PubMed Google Scholar
Cristina Festari
View author publications
You can also search for this author in PubMed Google Scholar
Nicholas J. Ashton
View author publications
You can also search for this author in PubMed Google Scholar
Gérard N. Bischof
View author publications
You can also search for this author in PubMed Google Scholar
Konstantinos Chiotis
View author publications
You can also search for this author in PubMed Google Scholar
Antoine Leuzy
View author publications
You can also search for this author in PubMed Google Scholar
Emma E. Wolters
View author publications
You can also search for this author in PubMed Google Scholar
Martin Walter
View author publications
You can also search for this author in PubMed Google Scholar
Gil D. Rabinovici
View author publications
You can also search for this author in PubMed Google Scholar
Maria Carrillo
View author publications
You can also search for this author in PubMed Google Scholar
Alexander Drzezga
View author publications
You can also search for this author in PubMed Google Scholar
Oskar Hansson
View author publications
You can also search for this author in PubMed Google Scholar
Agneta Nordberg
View author publications
You can also search for this author in PubMed Google Scholar
Rik Ossenkoppele
View author publications
You can also search for this author in PubMed Google Scholar
Victor L. Villemagne
View author publications
You can also search for this author in PubMed Google Scholar
Bengt Winblad
View author publications
You can also search for this author in PubMed Google Scholar
Giovanni Frisoni
View author publications
You can also search for this author in PubMed Google Scholar
Valentina Garibotto
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marina Boccardi.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Erratum

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boccardi, M., Dodich, A., Albanese, E. et al. Correction to: The Strategic Biomarker Roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update. Eur J Nucl Med Mol Imaging 48, 4525–4531 (2021). https://doi.org/10.1007/s00259-021-05549-z

Download citation

Published: 21 September 2021
Issue Date: December 2021
DOI: https://doi.org/10.1007/s00259-021-05549-z

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Correction to: The Strategic Biomarker Roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update

Author information

Authors and Affiliations

Corresponding author

Additional information

Publisher's note

Rights and permissions

About this article

Cite this article

Share this article

Search

Navigation